Plasma proteomic-based output complements tissue PD-L1 expression levels as a tool to assist therapeutic decisions for non-small cell lung cancer (NSCLC) patients BINYAMINA, Israel, May 25, 2023 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback